De Rubertis Francesco
- SEC CIK
- 0001601521
No open-market purchases or sales filed in the past year.
Current role at each company
- CNTA Centessa Pharmaceuticals plcDirectoras of Jun 24, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists De Rubertis Francesco as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | De Rubertis FrancescoDirector | PPurchase | +34.3K | $12.82 | +$440.1K | +58.0%93.5K after | 2 lots |
| Dec 2, 2021 (view filing) | Nov 30-Dec 1 | 2 days | De Rubertis FrancescoDirector | PPurchase | +97.2K | $12.24 | +$1.19M | New position92.7K after | 4 lots |
| Nov 30, 2021 (view filing) | Nov 26-29 | 4 days | De Rubertis FrancescoDirector | PPurchase | +68.5K | $11.64 | +$797.5K | +312.1%90.5K after | 4 lots |